New pill could keep breast cancer away longer
NCT ID NCT05780567
First seen Apr 26, 2026 · Last updated May 21, 2026 · Updated 5 times
Summary
This study tests a new drug called TQB3616 combined with standard hormone therapy to see if it can stop breast cancer from returning in people with HR-positive, HER2-negative breast cancer. About 1,946 women who have had surgery will receive either the new drug or a placebo, plus hormone therapy. The main goal is to see how long they stay cancer-free.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cancer Hospital Chinese Academy of Medical Science
Beijing, Beijing Municipality, 100021, China
-
Suining Central Hospital
Suining, Sichuan, 629099, China
-
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Guangzhou, Guangdong, 300020, China
Conditions
Explore the condition pages connected to this study.